Introducing Feedly for Biopharma

Streamline your biopharma intelligence.

Today, we’re excited to launch Feedly for Biopharma to help biopharma professionals cut through the noise. We’ve designed a collection of integrations and Leo models specifically designed to help you find the information you need, break barriers between teams, and streamline open-source intelligence.

280,000 biopharma professionals already use Feedly to keep up with the latest biopharma news and research insights about topics like diseases and conditions, genes, and competitors.

Biopharma is a competitive space. It is key for pharma and biotech companies to keep ahead of their competition and to be aware of the latest scientific and technological breakthroughs.

Learning more about the diseases and methodologies that are being researched by other biopharma companies can help you better prepare your strategic plans and research programs. According to a new analysis published in JAMA in March 2020, the cost to develop a new drug for a US biopharma company is $1 billion.

With hundreds of articles, scientific publications, and regulatory updates to read and organize every day, biopharma intelligence research is overwhelming. Finding the information you need in that sea of information is time-consuming and tedious. We’re launching Feedly for Biopharma to help biopharma professionals cut through the noise and save time.

Follow the biopharma sources you need

We’ve hand-picked the best sources in your industry to create biopharma bundles so you can keep up with trends. Choose any of the bundles below to see the different bundles of sources.

  • The Biopharma Business Bundle covers the top trade publications in the biopharma sector (Endpoints, FiercePharma, BioPharma Dive, etc.)
  • The Biopharma Regulatory Bundle allows you to track the latest regulatory and clinical trial updates in the biopharma sector (Eye on FDA, EMA Press Releases, Drugs.com, etc.)
  • The Science Journals Bundle helps you find the best peer-review publications to follow (JAMA, Nature, ScienceDaily, The Lancet, etc.)
  • The HealthTech Bundle covers digital health blogs and publications (MedCity News, Xconomy, MobiHealthNews, etc.)
Follow the biopharma source bundles you’re most interested in.

Define Leo priorities based on what you’re most interested in

Leo is your AI research assistant. Ask him to read your biopharma feeds and prioritize what matters to you. Leo can recognize genes, diseases and conditions, biopharma companies and startups, topics, trends, specific events, and more.

Prioritize the diseases and conditions you are researching
Prioritize the genes you are most interested in
Track the companies and startups in your space

Break down silos

Team Boards are the private spaces where you and your team can save the best content you discover in Feedly or on the web. You can bookmark, organize, and annotate content to share insights across your team and organization.

We’ve seen teams create tactical and operational Boards. For instance, you could build a Biotech Watchlist board with information about open innovation partnerships, or a Novel Drug Approvals board to keep the team up to speed on what your competitors are developing.

Once articles have been saved to a board, you can share them to the rest of the team via daily newsletters, Slack and Microsoft Teams notifications, or push them to other apps using our API.

Share the intelligence you collect in Feedly with other teams and apps

Streamline your biopharma intelligence

We’re excited to see how your team will declutter your feeds and dig deeper into the biopharma news that matter to you. Sign up today and discover Feedly for Biopharma.

If you’re interested in learning more about the Feedly for Biopharma roadmap, you can book a demo call by clicking on the button above. 2020 will be a thrilling year with new skills and bold experiments!

Leo understands biopharma companies

Track your competitors efficiently.

The biopharma space has become more and more competitive. It’s tedious to scan through hundreds of articles every day to track your competitors or find potential partnerships.

We are excited to announce that you can now prioritize biopharma companies with Leo, your AI research assistant.

Let’s walk through an example of how you could use Leo to prioritize news about competitors. Imagine you do market and competitive intelligence at a pharma company and you want to track biopharma companies.

Cut through the noise

You can train Leo to read your biopharma feeds and prioritize articles related to biopharma companies.

Leo prioritizes biopharma companies

Leo continuously reads the thousands of articles published in your feeds. It’s an efficient way to cut through the noise and keep up with the latest news about partnerships, methodologies and clinical trials.

You’re in control

We’ve trained Leo to understand 230 biopharma companies that are categorized into four different types of organizations:

  • The topic “Biopharma companies” allows you to prioritize the top global biopharma companies in the world, including Roche, Pfizer, etc.
  • The topic “Biotech companies” allows you to prioritize the top global biotech firms and startups, including Gilead, Arsenal Bio, etc.
  • The topic “Drug manufacturers” allows you to prioritize the top global drug manufacturing firms and startups, including Johnson & Johnson, Novartis, etc.
  • The topic “Generic pharmaceutical companies” allows you to prioritize the top global generic pharma companies, including Krka, Glenmark, etc.

Asking Leo to prioritize Biopharma companies in any of your biopharma feeds is as simple as creating a new Topic priority and selecting ‘Biopharma companies’ as the topic.

You can look into the companies that belong to those list topics by following this link.

Leo will be looking for all the top global biopharma companies

You can combine topics with +AND and +OR and create even more targeted priorities for Leo. For example, use +AND to focus on news related to breast cancer and biopharma companies.

Refine the priority to biopharma companies and breast neoplasms

If you find that a lot of the information you get about biopharma companies are noisy market reports, you can exclude market reports by using the +NOT in your Leo priority.

Mute out market reports from your Leo priority about biopharma companies

Leo continuously learns

Leo is smart. He continuously learns from your feedback. When Leo is wrong, you can use the ‘Less Like This’ down arrow button to let him know that an article he’s prioritized isn’t about biopharma companies.

Downvote an article to tell Leo when he’s wrong

See how Feedly for Biopharma can help you and your team dig deeper into the competitors you’re tracking.

Leo understands genes

Research genes and learn more about the latest breakthroughs more efficiently.

Drug development is a highly competitive space and the information about gene innovations is scattered across multiples sources, which makes the gene scouting process time consuming and tedious.

We are excited to announce that you can now prioritize genes with Leo, your AI research assistant.

Let’s walk through an example of how you could use Leo to prioritize a gene. Imagine you lead a research program about immuno-oncology at a biotech startup and you want to track any updates about IL33.

Cut through the noise

You can train Leo to read your biopharma feeds and prioritize articles related to IL33.

Leo prioritizes IL33 in your biopharma feeds

Leo continuously reads the thousands of articles published in your feeds. It’s an efficient way to cut through the noise and keep up with the latest news about methodologies and clinical trials.

You’re in control

We’ve trained Leo to understand 42,000 genes and 185,000 aliases from the NCBI database. This database belongs to the US National Library of Medicine and is used by leading websites such as PubMed and ClinicalTrials.gov.

Asking Leo to prioritize “IL33” in any of your biopharma feeds is as simple as creating a new Topic priority and selecting “IL33” as the topic.

When you create an “IL33” priority, Leo will be looking for all the aliases of “IL33“. What’s best is that these aliases were all disambiguated, which means Leo knows which aliases refer to genes, and which refer to unrelated topics, so you can be sure you’re prioritizing the right content.

Leo will be looking for IL33 and its 11 aliases as classified by NCBI

You can combine topics with +AND and +OR and create even more targeted priorities for Leo.

Leo continuously learns

Leo is smart. He continuously learns from your feedback. When Leo is wrong, you can use the ‘Less Like This’ down arrow button to let him know that an article he’s prioritized isn’t about cardiovascular diseases.

Downvote an article to tell Leo when he’s wrong

See how Feedly for Biopharma can help you and your team dig deeper into the genes you’re researching.

Leo understands diseases and conditions

Research diseases and learn about the latest breakthroughs more efficiently.

The biopharma space has become more and more competitive and it is now extremely tedious to scan through hundreds of articles every day to track down all the latest scientific and technological breakthroughs about a specific disease or condition you are interested about.

We’re excited to announce that you can now prioritize diseases and conditions with Leo, your AI research assistant.

Let’s walk through an example of how you could use Leo to prioritize diseases. Imagine you do market and competitive intelligence at a pharma company and you want to track clinical trials and regulatory updates about cardiovascular diseases.

Cut through the noise

You can train Leo to read your biopharma feeds and prioritize articles related to cardiovascular diseases.

Leo prioritizes cardiovascular disease articles in your Science Journals feed

Leo continuously reads the thousands of articles published in your feeds. It’s an efficient way to cut through the noise and keep up with the latest news about methodologies and clinical trials.

You’re in control

We’ve trained Leo to understand 5,000 diseases & conditions and 50,000 of their aliases from the MeSH database. This database belongs to the US National Library of Medicine and is used by leading websites such as PubMed and ClinicalTrials.gov.

Asking Leo to prioritize cardiovascular diseases in any of your biopharma feeds is as simple as creating a new Topic priority and selecting “cardiovascular diseases” as the topic.

When you create a ‘cardiovascular diseases’ priority, Leo will be looking for the aliases of cardiovascular diseases but also for all the disorders classified as cardiovascular diseases in MeSH.

Leo will be looking for all the disorders classified as cardiovascular diseases in MeSH

You can combine topics with +AND and +OR and create even more targeted priorities for Leo. For example, use +AND to focus on FDA approvals related to cardiovascular diseases.

Refine the priority to cardiovascular diseases and FDA approval

You can also ask Leo to look for a specific type of cardiovascular disease like coronary artery disease.

Prioritize a specific disease, such as coronary artery disease

Leo continuously learns

Leo is smart. He continuously learns from your feedback. When Leo is wrong, you can use the ‘Less Like This’ down arrow button to let him know that an article he’s prioritized isn’t about cardiovascular diseases.

Downvote an article to tell Leo when he’s wrong

See how Feedly for Biopharma can help you and your team dig deeper into the diseases and conditions you’re researching.